{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:45:22Z","timestamp":1792035922559,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T00:00:00Z","timestamp":1621036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T00:00:00Z","timestamp":1621036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2020JJ5221"],"award-info":[{"award-number":["2020JJ5221"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00280-021-04289-z","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T18:02:51Z","timestamp":1621101771000},"page":"343-357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["MiRNA-3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism"],"prefix":"10.1007","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2160-1222","authenticated-orcid":false,"given":"An","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,15]]},"reference":[{"issue":"10242","key":"4289_CR1","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW et al (2020) Pancreatic cancer. Lancet 395(10242):2008\u20132020","journal-title":"Lancet"},{"issue":"2","key":"4289_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00018-019-03278-z","volume":"77","author":"J Yang","year":"2020","unstructured":"Yang J, Ren B, Yang G et al (2020) The enhancement of glycolysis regulates pancreatic cancer metastasis. Cell Mol Life Sci 77(2):305\u2013321","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"4289_CR3","doi-asserted-by":"publisher","first-page":"188326","DOI":"10.1016\/j.bbcan.2019.188326","volume":"1873","author":"S Paternoster","year":"2020","unstructured":"Paternoster S, Falasca M (2020) The intricate relationship between diabetes, obesity and pancreatic cancer. Biochim Biophys Acta Rev Cancer 1873(1):188326","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"4289_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/gutjnl-2018-317424","volume":"69","author":"H Jiang","year":"2020","unstructured":"Jiang H, Liu X, Knolhoff BL et al (2020) Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion. Gut 69(1):122\u2013132","journal-title":"Gut"},{"issue":"1","key":"4289_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s13402-019-00476-6","volume":"43","author":"Z Yang","year":"2020","unstructured":"Yang Z, Zhao N, Cui J et al (2020) Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210. Cell Oncol (Dordr) 43(1):123\u2013136","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"4289_CR6","first-page":"33","volume":"56","author":"A Riera Leal","year":"2020","unstructured":"Riera Leal A, Ortiz-Lazareno PDAC, Jave-Su\u00e1rez LF et al (2020) 17beta-estradiol-induced mitochondrial dysfunction and Warburg effect in cervical cancer cells allow cell survival under metabolic stress. Int J Oncol 56(1):33\u201346","journal-title":"Int J Oncol"},{"issue":"5","key":"4289_CR7","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3390\/cancers12051119","volume":"12","author":"S Cassim","year":"2020","unstructured":"Cassim S, Vu\u010deti\u0107 M, \u017ddralevi\u0107 M et al (2020) Warburg and beyond: the power of Mitochondrial metabolism to collaborate or replace fermentative glycolysis in cancer. Cancers (Basel) 12(5):1119","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4289_CR8","doi-asserted-by":"publisher","first-page":"111713","DOI":"10.1016\/j.yexcr.2019.111713","volume":"386","author":"XX Wang","year":"2020","unstructured":"Wang XX, Yin GQ, Zhang ZH et al (2020) TWIST1 transcriptionally regulates glycolytic genes to promote the Warburg metabolism in pancreatic cancer. Exp Cell Res 386(1):111713","journal-title":"Exp Cell Res"},{"issue":"1","key":"4289_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12964-019-0502-8","volume":"18","author":"W Dai","year":"2020","unstructured":"Dai W, Meng X, Mo S et al (2020) FOXE1 represses cell proliferation andWarburg effect by inhibiting HK2 in colorectal cancer. Cell Commun Signal 18(1):7","journal-title":"Cell Commun Signal"},{"issue":"5","key":"4289_CR10","first-page":"1548","volume":"10","author":"L Liang","year":"2020","unstructured":"Liang L, Chen Y, Yu Y et al (2020) SLC25A18 has prognostic value in colorectal cancer and represses Warburg effect and cell proliferation via Wnt signaling. Am J Cancer Res 10(5):1548\u20131567","journal-title":"Am J Cancer Res"},{"issue":"3","key":"4289_CR11","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.3892\/mmr.2020.11295","volume":"22","author":"X Ren","year":"2020","unstructured":"Ren X, Su C (2020) Sphingosine kinase 1 contributes to doxorubicin resistance and glycolysis in osteosarcoma. Mol Med Rep 22(3):2183\u20132190","journal-title":"Mol Med Rep"},{"issue":"10","key":"4289_CR12","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41419-020-03123-3","volume":"11","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Tan X, Luo J et al (2020) The miR-30a-5p\/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma. Cell Death 11(10):902","journal-title":"Cell Death"},{"issue":"18","key":"4289_CR13","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1158\/0008-5472.CAN-13-1568","volume":"73","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Kjems J, Damgarrd CK et al (2013) Circular RNA and miR-7 in cancer. Cancer Res 73(18):5609\u20135612","journal-title":"Cancer Res"},{"issue":"5","key":"4289_CR14","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.31557\/APJCP.2019.20.5.1453","volume":"20","author":"P Mohammadi Torbati","year":"2019","unstructured":"Mohammadi Torbati P, Asadi F, Fard-Esfahani P et al (2019) Circulating miR-20a and miR-26a as biomarkers in prostate cancer. Asian Pac J Cancer Prev 20(5):1453\u20131456","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"4289_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Deng T, Liu R et al (2020) CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer 19(1):43","journal-title":"Mol Cancer"},{"issue":"28","key":"4289_CR16","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1038\/s41388-019-0817-3","volume":"38","author":"M He","year":"2019","unstructured":"He M, Jin Q, Chen C et al (2019) The miR-186-3p\/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells. Oncogene 38(28):5551\u20135565","journal-title":"Oncogene"},{"issue":"10","key":"4289_CR17","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41419-020-03123-3","volume":"11","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Tan X, Luo J et al (2020) The miR-30a-5p\/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma. Cell Death Dis 11(10):902","journal-title":"Cell Death Dis"},{"issue":"2","key":"4289_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/15384101.2019.1704537","volume":"19","author":"Z Hu","year":"2020","unstructured":"Hu Z, Cai M, Zhang Y et al (2020) miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1\/ATG14 pathway. Cell Cycle 19(2):193\u2013206","journal-title":"Cell Cycle"},{"issue":"11","key":"4289_CR19","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.prp.2017.09.011","volume":"213","author":"T Powr\u00f3zek","year":"2017","unstructured":"Powr\u00f3zek T, Ku\u017anar-Kami\u0144ska B, Dziedzic M et al (2017) The diagnostic role of plasma circulating precursors of miRNA-944 and miRNA-3662 for non-small cell lung cancer detection. Pathol Res Pract 213(11):1384\u20131387","journal-title":"Pathol Res Pract"},{"issue":"4","key":"4289_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.4149\/neo_2020_190730N689","volume":"67","author":"S Cheng","year":"2020","unstructured":"Cheng S, Huang Y, Lou C et al (2020) MiR-3662 suppresses cell growth, invasion and glucose metabolism by targeting HK2 in hepatocellular carcinoma cells. Neoplasma 67(4):773\u2013781","journal-title":"Neoplasma"},{"issue":"4","key":"4289_CR21","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.bbrc.2018.04.159","volume":"501","author":"K Yasui","year":"2018","unstructured":"Yasui K, Izumida M, Nakagawa T et al (2018) MicroRNA-3662 expression correlates with antiviral drug resistance in adult T-cell leukemia\/lymphoma cells. Biochem Biophys Res Commun 501(4):833\u2013837","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"4289_CR22","doi-asserted-by":"publisher","first-page":"e684","DOI":"10.1038\/cddis.2013.213","volume":"4","author":"MD Bullock","year":"2013","unstructured":"Bullock MD, Pickard KM, Nielsen BS et al (2013) Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression. Cell Death Dis 4(6):e684","journal-title":"Cell Death Dis"},{"issue":"1","key":"4289_CR23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12885-019-6501-8","volume":"20","author":"JG Zhang","year":"2020","unstructured":"Zhang JG, Zhou HM, Zhang X et al (2020) Hypoxic induction of vasculogeni- mimicry in hepatocellular carcinoma: role of HIF-1 alpha, RhoA\/ROCK and Rac1\/PAK signaling. BMC Cancer 20(1):32","journal-title":"BMC Cancer"},{"issue":"4","key":"4289_CR24","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1158\/1535-7163.MCT-18-0899","volume":"18","author":"G Maity","year":"2019","unstructured":"Maity G, Ghosh A, Gupta V et al (2019) CYR61\/CCN1 regulates dCK and CTGF and causes Gemcitabine-resistant phenotype in pancreatic Ductal Adenocarcinoma. Mol Cancer Ther 18(4):788\u2013800","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"4289_CR25","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/MPA.0000000000000807","volume":"46","author":"M Sierzega","year":"2017","unstructured":"Sierzega M, Pach R, Kulig P et al (2017) Prognostic implications of expression profiling for Gemcitabine-related genes (hENT1, dCK, RRM1, RRM2) in patients with resectable pancreatic Adenocarcinoma receiving adjuvant Chemotherapy. Pancreas 46(5):684\u2013689","journal-title":"Pancreas"},{"issue":"30","key":"4289_CR26","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1038\/onc.2014.325","volume":"34","author":"Z Chen","year":"2015","unstructured":"Chen Z, Wang Z, Guo W et al (2015) TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma. Oncogene 34(30):3946\u20133956","journal-title":"Oncogene"},{"issue":"39","key":"4289_CR27","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.1038\/s41388-020-01423-8","volume":"39","author":"A Kanamori","year":"2020","unstructured":"Kanamori A, Matsubara D, Saitoh Y et al (2020) Mint3 depletion restricts tumor malignancy of pancreatic cancer cells by decreasing SKP2 expression via HIF-1. Oncogene 39(39):6218\u20136230","journal-title":"Oncogene"},{"issue":"12","key":"4289_CR28","doi-asserted-by":"publisher","first-page":"10525","DOI":"10.18632\/oncotarget.24156","volume":"9","author":"T Katagiri","year":"2018","unstructured":"Katagiri T, Kobayashi M, Yoshimura M et al (2018) HIF-1 maintains a functional relationship between pancreatic cancer cells and stromal fibroblasts by upregulating expression and secretion of Sonic hedgehog. Oncotarget 9(12):10525\u201310535","journal-title":"Oncotarget"},{"issue":"3","key":"4289_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/cdd.2010.119","volume":"18","author":"MP Puiss\u00e9gur","year":"2011","unstructured":"Puiss\u00e9gur MP, Mazure NM, Bertero T et al (2011) MiR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ 18(3):465\u2013478","journal-title":"Cell Death Differ"},{"issue":"1","key":"4289_CR30","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s42003-020-01367-5","volume":"3","author":"J Seo","year":"2020","unstructured":"Seo J, Jeong DW, Park JW et al (2020) Fatty-acid-induced FABP5\/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells. Commun Biol 3(1):638","journal-title":"Commun Biol"},{"issue":"18","key":"4289_CR31","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1080\/15384101.2019.1638182","volume":"18","author":"C Liu","year":"2019","unstructured":"Liu C, Xing H, Guo C et al (2019) MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3\/HIF-1 signaling pathways. Cell Cycle 18(18):2215\u20132227","journal-title":"Cell Cycle"},{"issue":"7","key":"4289_CR32","doi-asserted-by":"publisher","first-page":"790","DOI":"10.4161\/cc.6.7.4084","volume":"6","author":"S Fulda","year":"2007","unstructured":"Fulda S, Debatin KM (2007) HIF-1-regulated glucose metabolism: a key to apoptosis resistance? Cell Cycle 6(7):790\u2013792","journal-title":"Cell Cycle"},{"issue":"4","key":"4289_CR33","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00018-018-2985-7","volume":"76","author":"Y Chen","year":"2019","unstructured":"Chen Y, Huang F, Deng L et al (2019) HIF-1alpha-derived cell-penetrating peptides inhibit ERK-dependent activation of HIF-1 and trigger apoptosis of cancer cells under hypoxia. Cell Mol Life Sci 76(4):809\u2013825","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"4289_CR34","doi-asserted-by":"publisher","first-page":"e0199827","DOI":"10.1371\/journal.pone.0199827","volume":"13","author":"R Silakit","year":"2018","unstructured":"Silakit R, Kitirat Y, Thongchot S et al (2018) Potential role of HIF-1-responsive microRNA210\/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells. PLoS ne 13(6):e0199827","journal-title":"PLoS ne"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-021-04289-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-021-04289-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-021-04289-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T16:04:06Z","timestamp":1624809846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-021-04289-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,15]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["4289"],"URL":"https:\/\/doi.org\/10.1007\/s00280-021-04289-z","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,15]]},"assertion":[{"value":"10 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that he has no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}